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The ability of the cardiorespiratory system (heart, lungs, blood) to deliver oxygen to exercising skeletal muscle
constrains maximum oxygen consumption _VO2max
 
, with cardiac output and the concentration of oxygen-carrying
haemoglobin ([Hb]) being key limiting parameters. Total blood volume (BV) is the sum of the plasma volume (PV)
and the total red cell volume. The measured [Hb] is dependent upon the total circulating mass of haemoglobin
(tHb-mass) and plasma volume (PV). While the proportion of oxygen carried in plasma is trivial (0.3 mL of oxygen
per 100 mL of plasma), each gram of Hb, contained in red blood cells, binds 1.39 mL of oxygen. As a result, the rela-
tionship between _VO2max and tHb-mass is stronger than that observed between _VO2max and [Hb] or BV. The glyco-
protein hormone erythropoietin drives red cell synthesis and, like simple transfusion of packed red blood cells, can
increase tHb-mass. An iron-containing haem group lies at the centre of the Hb molecule and, in situations of actual
or functional iron deficiency, tHb-mass will also rise following iron administration. However achieved, an increase in
tHb-mass also increases circulating oxygen-carrying capacity, and thus the capacity for aerobic phosphorylation. It is
for such reasons that alterations in _VO2max and exercise performance are proportional to those in arterial oxygen
content and systemic oxygen transport, a change in tHb-mass of 1 g being associated with a 4 mL · min−1 change
in _VO2max. Similarly, _VO2max increases by approximately 1% for each 3 g · L
−1 increase in [Hb] over the [Hb] range
(120 to 170 g · L−1). Surgery, like exercise, places substantial metabolic demands on the patient. Whilst subject to
debate, oxygen supply at a rate inadequate to prevent muscle anaerobiosis may underpin the occurrence of the
anaerobic threshold (AT), an important submaximal marker of cardiorespiratory fitness. Preoperatively, cardiopulmo-
nary exercise testing (CPET) can be used to determine AT and peak exertional oxygen uptake ( _VO2 peak) as mea-
sures of ability to meet increasing oxygen demands. The degree of surgical insult and the ability to meet the
resulting additional postoperative oxygen demand appear to be fundamental determinants of surgical outcome:
individuals in whom such ability is impaired (and thus those with reduced _VO2 peak and AT) are at greater risk of
adverse surgical outcome. This review provides an overview of the relationships between [Hb], tHb-mass, exercise
capacity, and surgical outcome and discusses the potential value of assessing tHb-mass over [Hb].
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Figure 1 Relationship between the percent change in [Hb] and
percent change in _VO2max. Each data point represents the mean of
each study using data obtained during the first 48 h after [Hb]
manipulation. Figure reproduced with permission from [33] using
data from nine studies [14-18,34-37].
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Introduction
Oxygen (O2) must be transported effectively from the
atmosphere to the tissues in order to maintain essential
metabolic pathways [1]. The heart, vasculature, and
blood function to deliver a sufficient supply of O2, as
well as metabolic substrate, to the tissues to allow effect-
ive resynthesis of adenosine triphosphate (ATP) via the
electron transport chain (ETC.) [2]. Importantly, O2 is
the final step in this process acting as the final electron
acceptor in the ETC. [3]. Without adequate O2 transfer
from the blood to the mitochondria, energy-generating
mechanisms within the mitochondria would come to a
halt [4]. At sites with insufficient O2 flow, anaerobic
glycolytic metabolism complements ongoing aerobic
ATP production, leading to a greater amount of lactic
acid [4].
It is generally accepted that the physiological limits
of the Fick equation determine the maximal rate at
which O2 can be transported from the environment to
the mitochondria and utilised to support oxidative
phosphorylation, termed the maximal oxygen uptake
_VO2max
 
[5]. This is highlighted in endurance-trained
athletes, where O2 transport is the most important limit-
ing factor of _VO2max , while mitochondrial O2 con-
sumption also limits _VO2max in untrained individuals
[6]. _VO2max is attained by the simultaneous increase in
_Q (SV × HR) and CaO2-CvO2, where _Q is the cardiac
output (determined by the stroke volume (SV) and the
heart rate (HR)) and CaO2-CvO2 is the arteriovenous
oxygen content difference. The ability to increase
CaO2-CvO2 depends primarily on the arterial O2
content and haemoglobin concentration [Hb] [4].
Haemoglobin is an iron-containing globular protein
pigment molecule carried within red blood cells (RBCs)
[7]. Haemoglobin carries almost all of the O2 in the
blood, with a trivial amount dissolved in plasma (0.3 mL
O2 per 100 mL of plasma) [8]. When fully saturated, as-
suming a normal [Hb] (e.g. 14 g · dL−1 in men) and a
constant oxygen capacity of haemoglobin (1.39 mL · g−1),
haemoglobin carries nearly 20 mL of O2 per 100 mL of
whole blood [7].
Total haemoglobin mass (tHb-mass) represents the
absolute mass of circulating haemoglobin in the body,
and can now be quickly, safely, cheaply, and reliably
measured using the optimised carbon monoxide (CO)
re-breathing method refined by Schmidt and Prommer
[9]. Total blood volume (BV) is the sum of plasma vol-
ume (PV) and total red cell volume. The measured [Hb]
is dependent upon the total circulating mass of haemo-
globin (tHb-mass) and plasma volume (PV). However,
the proportion of oxygen carried in plasma is trivial,
whilst each gram of Hb binds 1.39 mL of oxygen. Thus,
tHb-mass largely determines blood O2-carrying capacity.In addition, however, tHb-mass can increase BV via its
impact on erythrocyte volume [10]. A high BV is essential
for achieving a high _Q as observed in endurance athletes
[11,12]. Thus, tHb-mass may be a more sensitive marker
of blood O2 carrying capacity than using [Hb], and has
additional influences (e.g. via impacts on BV) on physical
performance than [Hb].
This review provides an overview of the relationships
between [Hb], tHb-mass, exercise capacity, and surgical
outcome, and discusses the potential value of assessing
tHb-mass over [Hb].
Manipulation of haemoglobin concentration
and physical performance
The link between the O2-carrying capacity of the blood
and indices of exercise capacity such as _VO2max has a
long history. This section will focus on the effects of ele-
vating and reducing [Hb] on markers of cardiorespira-
tory fitness.
Elevation of haemoglobin concentration and maximal
oxygen consumption
_VO2max rises when systemic [Hb] is increased by RBC infu-
sion [13-21] (Figure 1). _VO2max and/or exercise endurance
have also been shown to increase in circumstances where
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ant human erythropoietin (rhEPO) to healthy individuals
[22,23], athletes [23,24], haemodialysis patients [25,26], and
patients with heart failure [27,28], or through the increased
Hb synthesis following administration of iron supplements
[29]. Studies that have failed to find such a relationship
between [Hb] and exercise capacity [30] may in part be
explained by (i) a small quantity of blood being reinfused,
(ii) insufficient time for the body to adapt its normal [Hb]
post venesection, and (iii) inadequate storage of the RBCs
[31]. When these factors are appropriately controlled for,
elevating [Hb] is shown to increase _VO2max and endurance
performance [13]. Gledhill and colleagues [31,32] have
postulated that _VO2max increases by approximately 1% for
each 3 g · L−1 [Hb] over the [Hb] range (120 to 170 g · L−1).
Reduction of haemoglobin concentration and maximal
oxygen consumption
Early work by Ekblom and colleagues [14] demonstrated,
in four participants, that a 13% reduction in [Hb] (by
venesection of 800 mL of blood) lowered _VO2max by
10% (from 4.54 to 4.09 L · min−1) with a greater effect on
endurance time observed (reduced by 30% from 5.77 to
4.04 min). In the same study, an additional four partici-
pants underwent sequential venesection of 400, 800, and
1,200 mL of whole blood (at 4-day intervals) that
resulted in a reduction in [Hb] of 10%, 15%, and 18%,
respectively. These reductions were mirrored by a step-
wise impairment in _VO2max (6%, 10%, and 16% reduction)
and endurance times (13%, 21%, and 30% reduction).
Similar findings have been shown by a number of dif-
ferent authors including Balke et al. (9% decrease in
_VO2max 1 h after a 500-mL venesection) [34], Woodson
and colleagues (16% decline in _VO2max after 34% reduc-
tion of [Hb]) [35], Kanstrup and Ekblom (9% reduction
in _VO2max and 40% lower endurance time at the inten-
sity eliciting _VO2max after reducing [Hb] by 11% through
the removal of 900 mL blood) [36] and to a lesser extent
by Rowell et al. (4% decrease in _VO2max following a 14%
decrease in circulating [Hb] after repeated phlebotomies
totaling 700–1,000 mL over 5 days) [37].
Change in haemoglobin concentration and anaerobic
threshold
Compared to _VO2 peak or _VO2max, less is known about
the impact of changes in [Hb] on submaximal markers
of cardiorespiratory fitness such as the AT. The AT
represents the highest _VO2 (or running speed, power
output) that can be performed without developing a
sustained lactic acidosis [38].
Fritsch and colleagues [39] reported CPET in 16 young
healthy participants before and 2 days after a 450-mL
venesection that resulted in [Hb] being reduced from
14.5 to 13.0 g · dL−1 (not classified as anaemic if usingthe World Health Organisation recommendations [40]).
The AT was reduced following venesection when
expressed as a percentage of _VO2max (pre 68.5% versus
post 52%) and as an absolute _VO2 . Our laboratory [41]
has shown an independent association between pre-
operative [Hb] and AT after adjusting _VO2 values for
known confounders (age, sex, testing site, operation cat-
egory, diabetes, creatinine) and performing allometric
scaling to remove the influence of body size from _VO2
values. Causality cannot be conferred from these data,
but nonetheless demonstrate that those patients with the
lowest [Hb] displayed the lowest _VO2 values and vice
versa. Data from Japan [42] suggest that the AT is lower in
patients with iron deficiency anaemia than in non-athletic
controls (AT 15.9 ± 3.3 versus 21.3 ± 1.3 mL · kg−1 · min−1,
p < 0.01) and responds to increases in [Hb] following iron
supplementation ([Hb] 9.0 ± 1.8 to 12.1 ± 0.8 g · dL−1),
AT (20.9 ± 6.3 to 25.0 ± 8.0 mL · kg−1 · min−1, p < 0.001).Relationship between tHb-mass, blood volume, and
exercise capacity
The relationship between markers of cardiorespiratory
fitness and tHb-mass is stronger than that with BV or
[Hb] [43,44]. A high correlation between tHb-mass and
_VO2max (r = 0.97) was observed in the early 1950s by
Astrand [45], where differences in maximal aerobic cap-
acity between adults and children and between men and
women were related to differences in total haemoglobin
(see Figure 2). This initial investigation laid the founda-
tion for much of the subsequent work in relation to
tHb-mass and aerobic capacity.
Subsequently, undertaking a meta-analytical approach,
Schmidt and Prommer [43] pooled data from 611 sub-
jects. _VO2max was determined using either an incremen-
tal cycle ergometry test or treadmill protocol, with.
values obtained from treadmill exercise adjusted (specif-
ically reduced) by 7% to account for the greater muscle
mass utilised compared to cycling. tHb-mass was mea-
sured in all subjects using the CO re-breathing tech-
nique. Results revealed a high correlation (r = 0.79)
between _VO2max and tHb-mass. A similar close depend-
ency between BV and _VO2max (r = 0.76) was highlighted,
in keeping with early work by Convertino that showed a
similar relationship between total BV and _VO2max (r= 0.78)
[47]. No significant dependency of _VO2max on [Hb]
(males r = 0.03, females r = 0.12) or Hct (males r = 0.08,
females r = 0.11) was observed.
A number of other cross-sectional studies have demon-
strated a strong positive association between _VO2max
and tHb-mass including that by Gore and colleagues
[48] who studied a cohort of trained athletes, female
rowers (n = 17, r = 0.92, p < 0.0001), male rowers (n =
12, r = 0.79, p < 0.005) and male runners (n = 33, r = 0.48,
p = 0.005). Likewise, Heinicke et al. [49] investigated BV
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(downhill skiing, swimming, running, triathlon, cycling
junior, and cycling professional), finding that _VO2max
was significantly related to tHb-mass not only in the
whole group but also in all endurance disciplines.
Changes in tHb-mass and exercise capacity
Procedures to increase tHb-mass result in elevated _VO2max
, whereas the opposite is true when tHb-mass is reduced
[36], highlighting the importance of tHb-mass as a primary
determinant of _VO2max by determining O2-carrying capacity.
Elevation of tHb-mass and exercise capacity
When tHb-mass is increased through the use of rhEPO,
concomitant increases in _VO2max have been reported. Spe-
cifically, _VO2max increased by 6%–7% in 27 recreational
athletes after an increase in tHb-mass of 7%–12% and
both fitness and blood parameters returned to baseline
after cessation of rhEPO [50]. Similarly, a recent study
in 19 trained men showed an improved 3,000-m run-
ning time trial performance (11:08 ± 1:15 to 10:30 ±
1:07 min/sec, p < 0.001) following 4 weeks of rhEPO
administration. This improved performance coincided
with a rhEPO-induced increase in _VO2max (56.0 ± 6.2 toFigure 2 Relationship between total body haemoglobin
(between 100 and 900 g) and _VO2max in 94 individuals aged
7–30 years [45]. Figure reproduced with permission from [46].60.7 ± 5.8 mL · kg−1 · min−1, p < 0.001) and tHb-mass
(12.7 ± 1.2 to 15.2 ± 1.5 g · kg−1, p < 0.001).
What change in aerobic capacity can we expect for a
given change in tHb-mass? Linear regression analysis re-
vealed a change in tHb-mass of 1 g · kg−1 was associated
with a change in _VO2max of 4.4 mL · kg
−1 · min−1 (males
4.2 mL · kg−1 · min−1, females 4.6 mL · kg−1 · min−1) and a
change in BV of 1 mL blood per kilogram was related to
a change in _VO2max of 0.7 mL · kg
−1 · min−1 [43]. In 144
male athletes of various specialities with absolute
_VO2max values ranging from 1,010 to 6,320 mL · min
−1
and tHb-mass from 242 to 1,453 g, a change in 1 g of
haemoglobin was associated with a change in _VO2max by
around 4 mL · min−1 [51]. This is the same as reported
by Gore and colleagues [48] and very similar to that re-
cently reported in an excellent review article in this area
[10]. Understanding what change in aerobic capacity we
can expect from a change in tHb-mass is important
because it allows an accurate prediction of likely im-
provements in functional capacity as a result of an inter-
vention to improve tHb-mass.
Reduction of tHb-mass and exercise capacity
After 550 mL of whole blood had been withdrawn from
9 moderately trained male and female athletes, tHb-mass
was reduced on average by 77 ± 21 g [52]. This was sig-
nificantly associated with a decline in _VO2max of 255 ±
130 mL · min−1 (1 day post phlebotomy) and was still
decreased on day 10 (197 ± 116 mL · min−1). The
authors commented on a suppression of endurance
performance during this period of lower tHb-mass.
tHb-mass has also been shown to be reduced (868 ± 99
to 840 ± 94 g, p = 0.03) following a 30-day detraining
period (87% reduction in training hours) with a recip-
rocal decrease in _VO2max (4.83 ± 0.29 to 4.61 ± 0.41 L ·
min−1) observed [53]. Given these findings and that
tHb-mass is lower in healthy sedentary individuals
than in those who are athletically trained [54], would
sick patients have a lower tHb-mass by virtue of in-
activity? And might the relationship between lower
aerobic capacity and poorer operative outcome be in
part mediated through a sedentary lifestyle-associated
reduction in tHb-mass?
Mechanisms for reduced exercise capacity following
haematological changes
A reduction in [Hb] due to a fall in tHb-mass may im-
pair exercise capacity in a number of ways. Firstly, a re-
duction in CaO2 will reduce muscle O2 availability (O2
delivery) for the same muscle blood flow [55]. Secondly,
muscle O2-diffusing capacity is lower when [Hb] is re-
duced, which may be related to alterations in the intra-
capillary spacing of erythrocytes or slower dissociation
of O2 from [Hb] [56]. Thirdly, pulmonary diffusion is
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lating BV may also impact aerobic capacity by affecting
ventricular preload (diastolic function) via the Frank-
Starling mechanism, thus altering SV and _Q [11,57].
However, it appears that the predominant mechanism
explaining the detrimental impact of reduced [Hb] on
_VO2max and (to a greater extent) exercise endurance is the
lowered O2-carrying capacity of the blood [33], with [Hb]
being more important to _VO2max in the untrained than in
trained individuals [6]. This may have significant implica-
tions in patient populations.
Similar mechanisms may underpin the reduced AT ob-
served when [Hb] is reduced but this is a much-debated
and controversial concept [58,59]. The AT represents
the highest _VO2 (or running speed, power output) that
can be performed without developing a sustained lactic
acidosis [38]. When performing exercise above the AT,
it is suggested that the metabolic demands of tissues
(mitochondria) outstrips O2 supply, and aerobic ATP
resynthesis is supplemented by anaerobic metabolism
leading to increased lactate production relative to the rate
of glycolysis (i.e. increased lactate/pyruvate ratio) [60]. The
AT is therefore an important marker of cardiorespiratory
fitness as it provides an assessment of the ability of the
cardiovascular system to supply O2 at a rate adequate to
prevent muscle anaerobiosis [38]. A reduced capacity to
supply O2 to actively respiring tissues caused by low
[Hb] or cardiovascular disease conditions has the poten-
tial to reduce the AT.Surgical outcome, tHb-mass, and cardiorespiratory fitness
The measurement of tHb-mass (rather than [Hb]) in the
clinical setting may have important applications but
these remain relatively unexplored. For example, [Hb]
may vary as intravascular fluid shifts as a result of dis-
ease states or their treatment, making it a poor index of
oxygen-carrying capacity. [Hb] is determined by tHb-
mass and the total volume of blood. A substantial reduc-
tion in oxygen-carrying capacity, related to a low tHb-
mass, may thus be masked if PV is contracted, as may
be the case in many disease states. Similarly, increases in
intravascular volume may depress [Hb], even in the con-
text of a normal tHb-mass. Knowledge of tHb-mass and
[Hb] allows calculation of PV as a separate variable,
allowing evaluation of disease-related fluid shifts. The
degree of surgical blood loss might also be better quanti-
fied through the measurement of tHb-mass than [Hb].
More importantly, perhaps, tHb-mass may represent a
more sensitive marker of blood O2 transport capacity
than [Hb] in isolation [61].
Major surgery can be defined as any intervention
occurring in a hospital operating theatre involving the
incision, excision, manipulation, or suturing of tissue,
usually requiring regional or general anaesthesia orsedation [62]. The determinants of surgical outcome
(morbidity and mortality) are related to an interplay be-
tween the health and fitness of patients, the number and
severity of comorbidities present [63], and patient age as
well as surgery-related factors (emergency or planned,
mode, type, and duration). In addition, the systemic
inflammatory response caused by hormonal, immuno-
logical, and metabolic mediators [64] is essential for
effective tissue repair and healing after surgery. Effective
O2 delivery to the tissues during the hypermetabolic
postoperative period is thought to be a fundamental de-
terminant of surgical outcome [65,66] with patients who
are unable to raise O2 delivery to meet the increased
_VO2 requirement more frequently developing complica-
tions [67,68]. The cause of this uncoupling of O2 supply
and demand is multifactorial but may be predominantly
linked to the interaction between a patient's existing co-
morbidities (e.g. cardiac disease, respiratory disease, or
indeed any condition that impairs O2 delivery and/or
cardiac output) and the degree of surgical insult [69].
Impairment in the ability to meet these demands can
be determined preoperatively through the assessment of
exertional _VO2 peak and AT (by CPET); reductions in
both markers of functional capacity are associated with
an increased risk of perioperative morbidity and mortal-
ity [70-74]. The original work by Older and colleagues
almost 2 decades ago was the first to highlight the associ-
ation between low functional capacity by CPET and ad-
verse patient outcome following non-cardiopulmonary
surgery [75]. Specifically, a reduced cardiorespiratory
reserve, typically defined as an AT of less than 11 mL ·
kg−1 · min−1 being associated with an increased risk of
adverse postoperative outcome following major intra-
cavity surgery [74]. Similarly, impaired _VO2 peak has
been shown to predict worse postoperative outcome fol-
lowing major lung resection ( _VO2 peak <20 mL · kg
−1 ·
min−1 [76], <15 mL · kg−1 · min−1 [77]) and bariatric sur-
gery ( _VO2 peak <16 mL · kg
−1 · min−1) [78]. The reader is
referred to an excellent systematic review in this area
covering the role of CPET as a preoperative risk stratifi-
cation tool in non-cardiopulmonary surgery for more
details [74].
It is acknowledged that although the _VO2 response
from an exercise test is not directly comparable to that
in a postoperative patient, common with exercise, _VO2
postoperatively in major surgery is high [79]. For ex-
ample, preoperative resting _VO2 has been shown to in-
crease from 110 to approximately 170 mL · min−1 · m−2
[80,81] indicating a greater requirement for O2 following
surgery. In this context, tHb-mass may be important to
surgical outcome due to its role in determining O2 deliv-
ery. This may be related to the close linear relationship
that exists between tHb-mass, BV, _Q , and aerobic cap-
acity [10]. For example, a high BV is a prerequisite for a
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ing venous return and cardiac filling pressures [82,83].
Because tHb-mass in combination with BV also governs
[Hb] and therefore oxygen-carrying capacity, the effects
of tHb-mass on determining O2 delivery are twofold.
Given the close relationship between tHb-mass and
aerobic capacity and the association between markers of
cardiorespiratory fitness ( _VO2 peak and AT) and surgical
outcome, it would seem intuitive that a high tHb-mass
may confer a survival advantage in the perioperative set-
ting. If this is the case, then strategies aimed at elevating
tHb-mass may improve outcome (morbidity and mortal-
ity) following surgery, but this remains to be confirmed.
Given that anaemia is associated with an increased risk
of adverse surgical outcome, it would be surprising if this
relationship were not maintained for tHb-mass.Conclusion
Changes in [Hb] and tHb-mass are associated with re-
ciprocal alterations in exercise capacity proportional to
the change in oxygen-carrying capacity of the blood.
tHb-mass displays a stronger relationship with _VO2max
than [Hb] or BV. In the context of surgery, patients with
an inability to raise oxygen delivery to meet the in-
creased _VO2 requirement of the perioperative period will
more frequently develop complications. Impairment in
the ability to meet these demands can be determined pre-
operatively through the assessment of exertional _VO2
peak and AT (by CPET), reductions in both markers be-
ing associated with an increased risk adverse surgical
outcome. Whether differences in tHb-mass are associ-
ated with postoperative outcome is not known but an
interesting question given the high prevalence of pre-
operative anaemia itself being associated with an in-
creased risk of poor outcome. In addition, the extent to
which postoperative outcomes are dependent upon
interactions between [Hb], tHb-mass, and _VO2 is un-
known and whether strategies to increase tHb-mass re-
sult in improved surgical outcome remains to be
clarified.
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